Study protocol of the Edinburgh and Lothian Virus Intervention Study in Kids: a randomised controlled trial of hypertonic saline nose drops in children with upper respiratory tract infections (ELVIS Kids)

Sandeep Ramalingam, Catriona Graham, Katherine Oatey, Phillip Rayson, Andrew Stoddart, Aziz Sheikh, Steve Cunningham, ELVIS Kids Trial Investigators, Brittney Abernathy, Julie Baggot, Ruaridh Buchan, Gillian Black, Louise Frampton, Naomi Matos, Elinore McGivern, Rachel McKernan, Debbie Miller, Margaret Millar, Sheila Mortimer, Finny Paterson, Maxine Ramsay, Joan Thomson, Emma Ward, Jacqueline Waters, Sandeep Ramalingam, Catriona Graham, Katherine Oatey, Phillip Rayson, Andrew Stoddart, Aziz Sheikh, Steve Cunningham, ELVIS Kids Trial Investigators, Brittney Abernathy, Julie Baggot, Ruaridh Buchan, Gillian Black, Louise Frampton, Naomi Matos, Elinore McGivern, Rachel McKernan, Debbie Miller, Margaret Millar, Sheila Mortimer, Finny Paterson, Maxine Ramsay, Joan Thomson, Emma Ward, Jacqueline Waters

Abstract

Introduction: Edinburgh and Lothians' Viral Intervention Study Kids is a parallel, open-label, randomised controlled trial of hypertonic saline (HS) nose drops (~2.6% sodium chloride) vs standard care in children <7 years of age with symptoms of an upper respiratory tract infection (URTI).

Methods and analysis: Children are recruited prior to URTI or within 48 hours of developing URTI symptoms by advertising in areas such as local schools/nurseries, health centres/hospitals, recreational facilities, public events, workplaces, local/social media. Willing parents/guardians, of children <7 years of age will be asked to contact the research team at their local site. Children will be randomised to either a control arm (standard symptomatic care), or intervention arm (three drops/nostril of HS, at least four times a day, until 24 hours after asymptomatic or a maximum of 28 days). All participants are requested to provide a nasal swab at the start of the study (intervention arm: before HS drops) and then daily for four more days. Parent/guardian complete a validated daily diary, an end of illness diary, a satisfaction questionnaire and a wheeze questionnaire (day 28). The parent/guardian of a child in the intervention arm is taught to prepare HS nose drops. Parent/guardian of children asymptomatic at recruitment are requested to inform the research team within 48 hours of their child developing an URTI and follow the instructions already provided. The day 28 questionnaire determines if the child experienced a wheeze following illness. Participation in the study ends on day 28.

Ethics and dissemination: The study has been approved by the West of Scotland Research Ethics Service (18/WS/0080). It is cosponsored by Academic and Clinical Central Office for Research and Development-a partnership between the University of Edinburgh and National Health Service Lothian Health Board. The findings will be disseminated through peer-reviewed publications, conference presentations and via the study website.

Trial registration number: NCT03463694.

Keywords: community child health; neonatology; paediatric infectious disease & immunisation; primary care; virology.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
ELVIS Kids Patient Pathway when the child has an URTI at recruitment. ELVIS, Edinburgh and Lothians’ Viral Intervention Study; URTI, upper respiratory tract infection.
Figure 2
Figure 2
ELVIS Kids Patient Pathway when the child does not have an URTI at recruitment. ELVIS, Edinburgh and Lothians’ Viral Intervention Study; URTI, upper respiratory tract infection.

References

    1. Toivonen L, Schuez-Havupalo L, Karppinen S, et al. . Rhinovirus infections in the first 2 years of life. Pediatrics 2016;138:e20161309. 10.1542/peds.2016-1309
    1. Tarafder MR, Carabin H, Gyorkos TW, et al. . Diarrhea and colds in child day care centers: impact of various numerator and denominator definitions of illness episodes. Epidemiology 2009;20:796–9. 10.1097/EDE.0b013e3181ba468e
    1. Grüber C, Keil T, Kulig M, et al. . History of respiratory infections in the first 12 yr among children from a birth cohort. Pediatr Allergy Immunol 2008;19:505–12. 10.1111/j.1399-3038.2007.00688.x
    1. Ramalingam S, Graham C, Dove J, et al. . A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold. Sci Rep 2019;9:1015. 10.1038/s41598-018-37703-3
    1. Scotland I. How often do people in Scotland consult their GP practice and why? Reasons for consulting the GP practice: top 10 most common conditions seen, 2016. [Accessed 08 Feb 2016].
    1. Scotland I. Annual acute hospital activity and NHS beds information in Scotland - year ending 31 March 2016. Available:
    1. Schuez-Havupalo L, Karppinen S, Toivonen L, et al. . Association between infant swimming and rhinovirus-induced wheezing. Acta Paediatr 2014;103:1153–8. 10.1111/apa.12736
    1. Green CA, Yeates D, Goldacre A, et al. . Admission to hospital for bronchiolitis in England: trends over five decades, geographical variation and association with perinatal characteristics and subsequent asthma. Arch Dis Child 2016;101:140–6. 10.1136/archdischild-2015-308723
    1. le Roux DM, Myer L, Nicol MP, et al. . Incidence and severity of childhood pneumonia in the first year of life in a South African birth cohort: the Drakenstein child health study. Lancet Glob Health 2015;3:e95–103. 10.1016/S2214-109X(14)70360-2
    1. Centre for Disease Control . Common Cold and Runny Nose, 2016. Available: [Accessed 25 Dec 2016].
    1. Ramalingam S, Cai B, Wong J, et al. . Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels. Sci Rep 2018;8:13630. 10.1038/s41598-018-31936-y
    1. Kim HJ, Lee J-G, Kang JW, et al. . Effects of a low concentration hypochlorous acid nasal irrigation solution on bacteria, fungi, and virus. Laryngoscope 2008;118:1862–7. 10.1097/MLG.0b013e31817f4d34
    1. Yu MS, Park HW, Kwon HJ, et al. . The effect of a low concentration of hypochlorous acid on rhinovirus infection of nasal epithelial cells. Am J Rhinol Allergy 2011;25:40–4. 10.2500/ajra.2011.25.3545
    1. Rutala WA, Weber DJ. Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin Microbiol Rev 1997;10:597–610. 10.1128/CMR.10.4.597
    1. Jordan WE, Jones DV, Klein M. Antiviral effectiveness of chlorine bleach in household laundry use. Am J Dis Child 1969;117:313–6. 10.1001/archpedi.1969.02100030315010
    1. Castelão C, da Silva AP, Matos A, et al. . Association of myeloperoxidase polymorphism (G463A) with cervix cancer. Mol Cell Biochem 2015;404:1–4. 10.1007/s11010-015-2359-5
    1. Winterbourn CC, Kettle AJ. Redox reactions and microbial killing in the neutrophil phagosome. Antioxid Redox Signal 2013;18:642–60. 10.1089/ars.2012.4827
    1. Chen X, Lee K-A, Ha E-M, et al. . A specific and sensitive method for detection of hypochlorous acid for the imaging of microbe-induced HOCl production. Chem Commun 2011;47:4373–5. 10.1039/c1cc10589b
    1. Jantsch J, Schatz V, Friedrich D, et al. . Cutaneous Na+ storage strengthens the antimicrobial barrier function of the skin and boosts macrophage-driven host defense. Cell Metab 2015;21:493–501. 10.1016/j.cmet.2015.02.003
    1. Minton K. Antibacterial immunity: a pinch of salt. Nat Rev Immunol 2015;15:202. 10.1038/nri3835
    1. Zhang L, Mendoza-Sassi RA, Wainwright C. Nebulised hypertonic saline solution for acute bronchiolitis in infants. Cochrane Database Syst Rev 2013;7:CD006458.
    1. Zhang L, Mendoza-Sassi RA, Klassen TP, et al. . Nebulized hypertonic saline for acute bronchiolitis: a systematic review. Pediatrics 2015;136:687–701. 10.1542/peds.2015-1914
    1. Silver AH, Esteban-Cruciani N, Azzarone G, et al. . 3% Hypertonic Saline Versus Normal Saline in Inpatient Bronchiolitis: A Randomized Controlled Trial. Pediatrics 2015;136:1036–43. 10.1542/peds.2015-1037
    1. Everard ML, Hind D, Ugonna K, et al. . SABRE: a multicentre randomised control trial of nebulised hypertonic saline in infants hospitalised with acute bronchiolitis. Thorax 2014;69:1105–12. 10.1136/thoraxjnl-2014-205953
    1. Cunningham S, Unger SA. Nebulised hypertonic saline in bronchiolitis: take it with a pinch of salt. Thorax 2014;69:1065–6. 10.1136/thoraxjnl-2014-206210
    1. Grewal S, Klassen TP. The tale of 2 trials: disentangling contradictory evidence on hypertonic saline for acute bronchiolitis. JAMA Pediatr 2014;168:607–9. 10.1001/jamapediatrics.2014.423
    1. Baron J, El-Chaar G. Hypertonic saline for the treatment of bronchiolitis in infants and young children: a critical review of the literature. J Pediatr Pharmacol Ther 2016;21:7–26. 10.5863/1551-6776-21.1.7
    1. Badgett RG, Vindhyal M, Stirnaman JT, et al. . A living systematic review of nebulized hypertonic saline for acute bronchiolitis in infants. JAMA Pediatr 2015;169:788–9. 10.1001/jamapediatrics.2015.0681
    1. Slapak I, Skoupá J, Strnad P, et al. . Efficacy of isotonic nasal wash (seawater) in the treatment and prevention of rhinitis in children. Arch Otolaryngol Head Neck Surg 2008;134:67–74. 10.1001/archoto.2007.19
    1. Köksal T, Çizmeci MN, Bozkaya D, et al. . Comparison between the use of saline and seawater for nasal obstruction in children under 2 years of age with acute upper respiratory infection. Turk J Med Sci 2016;46:1004–13. 10.3906/sag-1507-18
    1. Kassel JC, King D, Spurling GK. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev 2010;3:CD006821. 10.1002/14651858.CD006821.pub2
    1. Jacobs B, Young NL, Dick PT, et al. . Canadian acute respiratory illness and flu scale (CARIFS): development of a valid measure for childhood respiratory infections. J Clin Epidemiol 2000;53:793–9. 10.1016/s0895-4356(99)00238-3

Source: PubMed

3
Abonnieren